Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA)

Wei Chen,Haiping Mao,Qian Zhou,Xiao Yang,Lanping Jiang,Qiong Feng,Xueqing Yu,Jun Ding,Naya Huang

doi:10.1136/bmjopen-2020-037842

Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA)

Wei Chen, Haiping Mao + Show 7 more

Open Access

https://doi.org/10.1136/bmjopen-2020-037842

Copy DOI

Journal: BMJ Open	Publication Date: Oct 1, 2020
Citations: 1	License type: open-access

Affiliation: First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangdong Provincial People's Hospital

#Outcomes In Peritoneal Dialysis Patients #Continuous Ambulatory Peritoneal Dialysis Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionThe prevalence of hyperuricaemia in peritoneal dialysis patients is quite high. Studies have demonstrated a correlation between hyperuricaemia and cardiovascular disease and treatment of hyperuricaemia reportedly reduces cardiovascular risk in...

Full Text